Treated hydrocephalus in individuals with myelomeningocele in the National Spina Bifida Patient Registry

Restricted access

OBJECTIVE

Although the majority of patients with myelomeningocele have hydrocephalus, reported rates of hydrocephalus treatment vary widely. The purpose of this study was to determine the rate of surgical treatment for hydrocephalus in patients with myelomeningocele in the National Spina Bifida Patient Registry (NSBPR). In addition, the authors explored the variation in shunting rates across NSBPR institutions, examined the relationship between hydrocephalus, and the functional lesion level of the myelomeningocele, and evaluated for temporal trends in rates of treated hydrocephalus.

METHODS

The authors queried the NSBPR to identify all patients with myelomeningoceles. Individuals were identified as having been treated for hydrocephalus if they had undergone at least 1 hydrocephalus-related operation. For each participating NSBPR institution, the authors calculated the proportion of patients with treated hydrocephalus who were enrolled at that site. Logistic regression was performed to analyze the relationship between hydrocephalus and the functional lesion level of the myelomeningocele and to compare the rate of treated hydrocephalus in children born before 2005 with those born in 2005 or later.

RESULTS

A total of 4448 patients with myelomeningocele were identified from 26 institutions, of whom 3558 patients (79.99%) had undergone at least 1 hydrocephalus-related operation. The rate of treated hydrocephalus ranged from 72% to 96% among institutions enrolling more than 10 patients. This difference in treatment rates between centers was statistically significant (p < 0.001). Insufficient data were available in the NSBPR to analyze reasons for the different rates of hydrocephalus treatment between sites. Multivariate logistic regression demonstrated that more rostral functional lesion levels were associated with higher rates of treated hydrocephalus (p < 0.001) but demonstrated no significant difference in hydrocephalus treatment rates between children born before versus after 2005.

CONCLUSIONS

The rate of hydrocephalus treatment in patients with myelomeningocele in the NSBPR is 79.99%, which is consistent with the rates in previously published literature. The authors’ data demonstrate a clear association between functional lesion level of the myelomeningocele and the need for hydrocephalus treatment.

ABBREVIATIONS CDC = Centers for Disease Control and Prevention; MOMS = Management of Myelomeningocele Study; NSBPR = National Spina Bifida Patient Registry.
Article Information

Contributor Notes

Correspondence Brandon G. Rocque: University of Alabama at Birmingham, AL. brandon.rocque@childrensal.org.INCLUDE WHEN CITING Published online August 24, 2018; DOI: 10.3171/2018.5.PEDS18161.Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Headings
References
  • 1

    Adzick NSThom EASpong CYBrock JW IIIBurrows PKJohnson MP: A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:99310042011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Bowman RMBoshnjaku VMcLone DG: The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children’s Memorial Hospital. Childs Nerv Syst 25:8018062009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Chakraborty ACrimmins DHayward RThompson D: Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatr 1:3613652008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Johnson MPSutton LNRintoul NCrombleholme TMFlake AWHowell LJ: Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 189:4824872003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Kim IHopson BAban IRizk EBDias MSBowman R: Decompression for Chiari malformation type II in individuals with myelomeningocele in the National Spina Bifida Patient Registry. J Neurosurg Pediatr [epub ahead of print August 24 2018. DOI: 10.3171/2018.5.PEDS18160]

    • Search Google Scholar
    • Export Citation
  • 6

    Laskay NMBArynchyna AAMcClugage SG IIIHopson BShannon CDitty B: A comparison of the MOMS trial results to a contemporaneous, single-institution, postnatal closure cohort. Childs Nerv Syst 33:6396462017

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Patet JDLapras CGuilburd JNLapras C: [Spina bifida aperta—myelomeningocele. Hydrocephalus.] Neurochirurgie 34 (Suppl 1):47521988 (Fr)

  • 8

    Phillips BCGelsomino MPownall ALOcal ESpencer HJO’Brien MS: Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele. J Neurosurg Pediatr 14:1671722014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Piatt JH Jr: Treatment of myelomeningocele: a review of outcomes and continuing neurosurgical considerations among adults. J Neurosurg Pediatr 6:5155252010

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Rintoul NESutton LNHubbard AMCohen BMelchionni JPasquariello PS: A new look at myelomeningoceles: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 109:4094132002

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Sankhla SKhan GM: Reducing CSF shunt placement in patients with spinal myelomeningocele. J Pediatr Neurosci 4:292009

  • 12

    Sawin KJLiu TWard EThibadeau JSchechter MSSoe MM: The National Spina Bifida Patient Registry: profile of a large cohort of participants from the first 10 clinics. J Pediatr 166:444450 450.e12015

    • Search Google Scholar
    • Export Citation
  • 13

    Stein SCSchut L: Hydrocephalus in myelomeningocele. Childs Brain 5:4134191979

  • 14

    Thibadeau JKWard EASoe MMLiu TSwanson MSawin KJ: Testing the feasibility of a National Spina Bifida Patient Registry. Birth Defects Res A Clin Mol Teratol 97:36412013

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15

    Tulipan NWellons JC IIIThom EAGupta NSutton LNBurrows PK: Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 16:6136202015

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 461 461 62
Full Text Views 143 143 2
PDF Downloads 115 115 2
EPUB Downloads 0 0 0
PubMed
Google Scholar